Erika Borlenghi

4.0k total citations
59 papers, 1.2k citations indexed

About

Erika Borlenghi is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Erika Borlenghi has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 21 papers in Public Health, Environmental and Occupational Health and 18 papers in Genetics. Recurrent topics in Erika Borlenghi's work include Acute Myeloid Leukemia Research (26 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Erika Borlenghi is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Erika Borlenghi collaborates with scholars based in Italy, United States and Germany. Erika Borlenghi's co-authors include Giuseppe Rossi, Alessandra Tucci, Chiara Cattaneo, Alessandro Re, Chiara Bottelli, Samantha Ferrari, Monica Drera, Salvatore Casari, Chiara Pagani and Giampiero Carosi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Erika Borlenghi

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika Borlenghi Italy	19	491	462	334	229	216	59	1.2k
Mauricette Michallet France	19	484 1.0×	266 0.6×	135 0.4×	209 0.9×	365 1.7×	73	1.2k
Byung‐Sik Cho South Korea	24	1.5k 3.1×	560 1.2×	459 1.4×	130 0.6×	353 1.6×	189	2.3k
Parastoo B. Dahi United States	18	494 1.0×	930 2.0×	115 0.3×	211 0.9×	141 0.7×	111	1.7k
Andrea Mengarelli Italy	19	434 0.9×	279 0.6×	114 0.3×	79 0.3×	130 0.6×	64	1.0k
Molly Maloy United States	22	635 1.3×	834 1.8×	181 0.5×	121 0.5×	124 0.6×	111	1.6k
Saveria Capria Italy	19	543 1.1×	442 1.0×	183 0.5×	209 0.9×	163 0.8×	70	1.3k
Francesc Fernández‐Avilés Spain	24	1.2k 2.3×	532 1.2×	239 0.7×	144 0.6×	179 0.8×	89	1.8k
Mike Potter United Kingdom	24	823 1.7×	409 0.9×	242 0.7×	118 0.5×	119 0.6×	63	1.7k
J. W. Andersen United States	10	453 0.9×	290 0.6×	140 0.4×	132 0.6×	203 0.9×	13	960
Brett Glotzbecker United States	18	753 1.5×	484 1.0×	178 0.5×	111 0.5×	99 0.5×	53	1.3k

Countries citing papers authored by Erika Borlenghi

Since Specialization

Citations

This map shows the geographic impact of Erika Borlenghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Borlenghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Borlenghi more than expected).

Fields of papers citing papers by Erika Borlenghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Borlenghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Borlenghi. The network helps show where Erika Borlenghi may publish in the future.

Co-authorship network of co-authors of Erika Borlenghi

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Borlenghi. A scholar is included among the top collaborators of Erika Borlenghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Borlenghi. Erika Borlenghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giacomo, Danika Di, Valentina Pierini, Roberta La Starza, et al.. (2021). Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement. Annals of Hematology. 101(2). 297–307. 8 indexed citations

Sommer, Kathrin, Marco Vignetti, Francesco Cottone, et al.. (2020). Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burden. BMJ Supportive & Palliative Care. 12(2). 182–186. 2 indexed citations

Mannelli, Francesco, Giacomo Gianfaldoni, Sara Bencini, et al.. (2020). Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia. American Journal of Hematology. 95(11). 1304–1313.

Malagola, Michele, Nicola Polverelli, Valeria Cancelli, et al.. (2019). Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?. SHILAP Revista de lepidopterología. 2019. 1–4. 1 indexed citations

Zappasodi, Patrizia, Laura Marbello, Erika Borlenghi, et al.. (2018). Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network. Annals of Hematology. 97(11). 2107–2115. 2 indexed citations

Schieppati, Francesca, Angela Passi, Erika Borlenghi, et al.. (2017). Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia. Blood. 130. 3931–3931. 1 indexed citations

Chiarini, Marco, Viviana Giustini, Francesco Buccisano, et al.. (2017). Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk. Blood. 130. 2697.

Cattaneo, Chiara, Margherita Oberti, Cristina Skert, et al.. (2016). Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients. Hematological Oncology. 35(4). 828–834. 34 indexed citations

Cerqui, Elisa, Francesca Schieppati, Erika Borlenghi, et al.. (2015). Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience. Leukemia & lymphoma. 56(11). 3129–3134. 1 indexed citations

10.

Borlenghi, Erika, Chiara Pagani, Massimo Bernardi, et al.. (2014). Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL). Blood. 124(21). 279–279. 3 indexed citations

11.

Cattaneo, Chiara, Mario Tumbarello, Cristina Skert, et al.. (2013). Relapsing bloodstream infections during treatment of acute leukemia. Annals of Hematology. 93(5). 785–790. 17 indexed citations

12.

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2012). Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).. Blood. 120(21). 2573–2573.

13.

Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145. 24 indexed citations

14.

Cortelazzo, Sergio, Tamara Intermesoli, Elena Oldani, et al.. (2011). Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma. Annals of Hematology. 91(1). 73–82. 28 indexed citations

15.

Ferrara, Felicetto, et al.. (2010). Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.. PubMed. 30(9). 3845–9. 14 indexed citations

16.

Bassan, R, Tamara Intermesoli, Elena Oldani, et al.. (2008). Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09. Haematologica. 93. 366–367. 4 indexed citations

17.

Cavattoni, Irene, Enrico Morello, Elena Oldani, et al.. (2008). Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: An Update of the Northern Italy Leukemia Group (NILG) Experience. Blood. 112(11). 4385–4385. 1 indexed citations

18.

Tucci, Alessandra, Chiara Bottelli, Samantha Ferrari, et al.. (2007). A Comprehensive Geriatric Assessment Is More Effective Than Clinical Judgement to Prospectively Identify Elderly Patients with Diffuse Large Cell Lymphoma Who Can Tolerate Full-Dose Anthracyclin-Based Treatment and Achieve the Same Outcome as Young Patients.. Blood. 110(11). 3441–3441.

19.

Re, Alessandro, Fabio Facchetti, Erika Borlenghi, et al.. (2007). Fatal hemophagocytic syndrome related to active human herpesvirus‐8/Kaposi sarcoma‐associated herpesvirus infection in human immunodeficiency virus‐negative, non‐transplant patients without related malignancies. European Journal Of Haematology. 78(4). 361–364. 18 indexed citations

20.

Tucci, Alessandra, Maddalena Motta, Marco Ungari, et al.. (2005). The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.. PubMed. 90(3). 348–52. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact